A phase II randomised controlled trial of intranasal oxytocin in anorexia nervosa. Maguire S, Kesby A, Brownlow R, Hunt GE, et al. Psychoneuroendocrinology 2024;164:107032.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Maguire S, Kesby A, Brownlow R, Hunt GE, et al. A phase II randomised controlled trial of intranasal oxytocin in anorexia nervosa. Psychoneuroendocrinology 2024;164:107032.
PMID: 38520886